The resistance to the antilipolytic effect of insulin over the number of triglycerides in excess, together with the de novo synthesis of free fatty acids in the liver, results in a progressive increase in free fatty acids and subsequent dyslipidemia [71]. Here, INS is linked to metabolic syndrome.